Table 1 Comparison of the baseline characteristics between the saffron and placebo groups
Variable | Group | P-value | |
|---|---|---|---|
Saffron N = 38 | Placebo N = 38 | ||
Gender N (%) | |||
Male N(%) | 24(60) | 24(60) | 0.99 |
Female N(%) | 16 (40) | 16(40) | |
BMI (kg/m2) | 26.84 (25.46–27.23) | 26.84 (25.05–27.39) | 0.79 |
Age (years) | 41.27 ± 9.77 | 40.77 ± 10.07 | 0.67 |
Asthma severity | |||
Mild N(%) | 14 (35) | 15 (37.5) | 0.81 |
Moderate N(%) | 26 (65) | 25 (62.5) | |
Systolic pressure (mm Hg) | 110.00 (110.00–120.00) | 110.00 (110.00–120.00) | 0.15 |
Diastolic pressure (mm Hg) | 80.00 (70.00–80.00) | 80.00 (70.00–80.00) | 0.85 |
LDL-C (mg/dl) | 118.54 ± 36.03 | 120.74 ± 27.35 | 0.76 |
HDL-C (mg/dl) | 45.32 ± 13.46 | 45.57 ± 13.01 | 0.93 |
TG (mg/dl) | 159.83 ± 41.20 | 149.30 ± 48.27 | 0.31 |
Total-C (mg/dl) | 196.82 ± 42.11 | 192.74 ± 28.93 | 0.62 |
Eosinophil (%) | 5.60 (3.00–7.45) | 4.90 (3.85–6.50) | 0.54 |
Basophil (%) | 0.6 (0.3–1.05) | 0.6 (0.4–1.20) | 0.53 |
Physical activity (MET-min/week) | 676.50 (231–2704) | 693 (231–3446.50) | 0.71 |
Symptoms (frequency per day) | |||
Shortness of breath during the day | 1.00 (0.03–1.50) | 1.00 (0.04–2.00) | 0.73 |
Shortness of breath during the night | 0.71 (0.00–1.87) | 0.20 (0.00–1.87) | 0.64 |
Waking up due to asthma symptoms | 1.00 (0.00–1.00) | 0.00 (0.00–1.00) | 0.12 |
Activity Limitation | 0.38 (0.14–1.00) | 1.00 (0.10–1.87) | 0.22 |
Salbutamol spray consumption | 1.25 (0.02–2.00) | 1.00 (0.33–2.00) | 0.79 |
Infant Feeding N (%) | |||
Breast feeding | 30 (75) | 32 (80) | |
Milk Powder | 5 (12.5) | 4 (10) | 0.37 |
Breast feeding and milk powder | 5 (12.5) | 4 (10) | |
The age of the onset of asthma (years) | 33.50 (23.50–42.50) | 30 (25.00–39.00) | 0.96 |